Company information:
Pharmenable Therapeutics Limited (No: 10430444)
Address: C/O AZETS, COMPASS HOUSE, VISION PARK, HISTON, CAMBRIDGE, CAMBRIDGESHIRE, CB24 9AD, UNITED KINGDOM
Status: Active
Incorporated: 17-Oct-2016
Accounts Next Due: 31-Dec-2024
Next Confirmation Statement Due: 03-Nov-2025
Industry Class: 74909 - Other professional, scientific and technical activities n.e.c.
Current Director: KEITH STUART BLUNDY ( DOB: Apr-1960 From: Nov-2022 )
Current Director: IAN JAMES COLLINS ( DOB: May-1967 From: Dec-2023 )
Current Director: JANE ELIZABETH DANCER ( DOB: Feb-1963 From: Dec-2019 )
Current Director: GAYNOR MARY FRYERS ( DOB: Mar-1957 From: Apr-2019 )
Current Director: PETER MCPARTLAND ( DOB: Jan-1954 From: Apr-2020 )
Current Director: JEFFREY BERNARD MOORE ( DOB: Sep-1965 From: Nov-2022 )
Current Director: JEFFREY MOORE ( DOB: Sep-1965 From: Nov-2022 )
Current Director: HANNAH FIONA SORE ( DOB: Jul-1977 From: Oct-2016 )
Resigned Director: GAYNOR MARY FRYERS ( DOB: Mar-1957 From: Apr-2019 To: Nov-2023 )
Resigned Director: CHRISTINE JANET MARTIN ( DOB: Dec-1969 From: Apr-2020 To: Nov-2022 )
Resigned Director: NATALIA MATEU ( DOB: Aug-1983 From: Jul-2017 To: Nov-2022 )
Persons of Significant Control:
Dr Hannah Fiona Sore, 2 Hazlewell Court Bar Road, Lolworth, Cambridge, CB23 8DS, United Kingdom: Ownership of shares – More than 25% but not more than 50% (Notified: 2016-10-17, Ceased: 2020-05-01)
Dr Natalie Mateu, 2 Hazlewell Court Bar Road, Lolworth, Cambridge, CB23 8DS, United Kingdom: Ownership of shares – More than 25% but not more than 50% (Notified: 2017-07-18, Ceased: 2020-05-01)
Company Accounts Summary (£)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Chart |
|---|---|---|---|---|---|---|---|
| Fixed assets | 113 | 5,149 | 10,921 | 10,457 | 10,163 | 0.0,113.0,5149.0,10921.0,10457.0,10163.0 | |
| Current assets | 2,327 | 42,449 | 49,423 | 1,538,723 | 951,596 | 4,418,056 | 2327.0,42449.0,49423.0,1538723.0,951596.0,4418056.0 |
| Prepayments and accrued income, not expressed within current asset subtotal | 2,250 | 6,545 | 34,081 | 22,367 | 51,350 | 0.0,2250.0,6545.0,34081.0,22367.0,51350.0 | |
| Net current assets (liabilities) | -4,799 | 9,296 | -4,209 | 1,543,960 | 932,929 | 4,376,954 | -4799.0,9296.0,-4209.0,1543960.0,932929.0,4376954.0 |
| Total assets less current liabilities | -4,799 | 9,409 | 940 | 1,554,881 | 943,386 | 4,387,117 | -4799.0,9409.0,940.0,1554881.0,943386.0,4387117.0 |
| Net assets (liabilities) | -4,799 | 9,409 | 940 | 1,554,881 | 943,386 | 4,387,117 | -4799.0,9409.0,940.0,1554881.0,943386.0,4387117.0 |
| Equity / share capital and reserves | -4,799 | 9,409 | 940 | 1,554,881 | 943,386 | 4,387,117 | -4799.0,9409.0,940.0,1554881.0,943386.0,4387117.0 |